Clinical Trial Update: Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial update on dexamethasone for ARDS caused by COVID-19; the study status shows TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Dr. Negrin University Hospital | Conditions: Acute Respiratory Distress Syndrome Caused by COVID-19 | Phase 4 | Status: TERMINATED